About Embolx
Embolx is a Healthcare company based in Sunnyvale (United States) founded in 2013. Catheter-based system for localized cancer therapy is being developed. It operates on a Direct-to-Consumer (D2C) and HealthTech model. Embolx has raised $500 thousand across 3 funding rounds from investors including HHS. Embolx offers products and services including Sniper Balloon Occlusion Microcatheter, Soldier High Flow Microcatheter, and Sniper G3 Balloon Occlusion Microcatheter. Its focus areas include Medical Devices and Interventional Radiology. Its legal entity is Embolx, Inc. Its competitors include TriSalus Life Sciences, Proprio and ClearPoint Neuro; 3 of its 3 listed competitors have raised funding.
Company details
Embolx is engaged in the development and innovation of microcatheters for arterial embolization procedures. Solutions are provided for targeted medical interventions using high-pressure and low-pressure techniques. The healthcare sector, specifically interventional radiology, is served through products like the Sniper Balloon Occlusion Microcatheter and Soldier High Flow Microcatheter. Advancements are continuously made, as seen with the release of the Sniper G3, enhancing efficiency and usability in medical treatments.
- Headquarters Sunnyvale, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website embolx.com
- Social LinkedIn X YouTube
- Legal Name Embolx, Inc.
- Total Equity Funding$500K (USD)
in 3 rounds
- Latest Funding Round$1.86M (USD), Grant
Sep 2015
- Investors
Products & Services of Embolx
Embolx offers a comprehensive portfolio of products and services, including Sniper Balloon Occlusion Microcatheter, Soldier High Flow Microcatheter, and Sniper G3 Balloon Occlusion Microcatheter.
Used for targeted arterial embolization in medical procedures.
Designed for high-flow delivery in embolization treatments.
Enhanced microcatheter for efficient and targeted embolization.
Apps and channels of Embolx
its YouTube channel Embolx Inc has 35 subscribers and 8 videos.
Videos from Embolx
The most watched videos on Embolx's YouTube channel, Embolx Inc (35 subscribers). Click a video to play it here.
More on Embolx Inc.
Funding Insights of Embolx
Embolx has successfully raised a total of $500K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.86 million completed in September 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $500,000
- Total Rounds 3
- Last Round Grant — $1.86M
- First Round $250,000
(Feb 2014)
- Investors Count 1
All 3 funding rounds of Embolx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2015 | $1.86M | Grant | – | – | |
| May 2014 | $250,000 | Seed | – | – | – |
| Feb 2014 | $250,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Embolx
Embolx has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Embolx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Embolx
8 people are tracked at Embolx (1 in leadership, 4 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Michael Allen | President & CEO | Leadership |
Tianhong Xu | Board Member | Board & advisors |
Norman Gitis | Chairman | Board & advisors |
Frank Grillo | Secretary | Board & advisors |
Paul Rogan | Board Member | Board & advisors |
Tom Breton | Manager of Research & Development | Team |
Haley McGregor | Marketing Manager | Team |
Chris Goodrow | Southwest Territory Sales Manager | Team |
Complete people profiles for Embolx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Embolx
3 dated milestones of Embolx across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Embolx is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Grant, of $1.9M.
Competitors of Embolx
Embolx has 3 listed competitors in our database, 3 of them funded. They include TriSalus Life Sciences, Proprio and ClearPoint Neuro.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| trisaluslifesci.com | 2009 | Westminster, United States | $83.37M | 100 | Developer of drug delivery devices to treat cancers | |
| propriovision.com | 2016 | Seattle, United States | $74.25M | 52 | Visualization systems for surgical procedures are developed using machine learning. | |
| clearpointneuro.com | 1998 | Irvine, United States | $17.04M | 38 | Software and hardware solutions for MRI-guided surgical planning are provided. |
Detailed competitors of Embolx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Embolx
The website of Embolx (embolx.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 99.1% vs previous month
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as Embolx (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Embolx
Complete news archive for Embolx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Embolx
Embolx was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Embolx is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Embolx is a funded company, having raised a total of $500K across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Feb 2014.
Embolx is engaged in the development and innovation of microcatheters for arterial embolization procedures. Solutions are provided for targeted medical interventions using high-pressure and low-pressure techniques. The healthcare sector, specifically interventional radiology, is served through products like the Sniper Balloon Occlusion Microcatheter and Soldier High Flow Microcatheter. Advancements are continuously made, as seen with the release of the Sniper G3, enhancing efficiency and usability in medical treatments.
Embolx's top competitors include Proprio, TriSalus Life Sciences and ClearPoint Neuro.
Embolx offers Sniper Balloon Occlusion Microcatheter, Soldier High Flow Microcatheter, and Sniper G3 Balloon Occlusion Microcatheter.
Embolx has 1 investor. Key investors include HHS.
Embolx operates through Embolx, Inc..